December 15, 2021

COVID-19 Vaccine Response in Patients With Non-Hodgkin Lymphoma

Written by Nikki Meyer Edited by Lauren Weinand, M.D. Patients with cancer are a critical group in which to analyze COVID-19 vaccine response. This observational study, published in Blood, and presented at the 2021 ASH Annual Meeting & Exposition, examined COVID-19 vaccine response in patients with non-Hodgkin lymphomas (NHL) and chronic lymphocytic leukemia (CLL) who received the...

The Impact of Social Determinants on NMOSD

Neuromyelitis optica spectrum disorder (NMOSD) disproportionately affects Black and Hispanic/Latino individuals. Black individuals face a higher risk of developing NMOSD and an increased associated mortality from NMOSD. Moreover, Black and Hispanic/Latino individuals face greater disease severity and faster disease progression than white individuals. Researchers at the Keck School of Medicine at the University of Southern...

How NMOSD Differs from MS

Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are two different autoimmune disorders that share several similarities. Both disorders attack the central nervous system (CNS) and have some of the same symptoms, such as blurry vision, numbness, tingling, and limb weakness. In fact, the disorders are so similar that 42.5% of patients with NMOSD...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.